Mtor Regulates TLR-induced C-Fos and Th1 Responses to HBV and HCV Vaccines

Li He,Aiping Zang,Min Du,Dapeng Ma,Chuanping Yuan,Chun Zhou,Jing Mu,Huanjing Shi,Dapeng Li,Xulin Huang,Qiang Deng,Jianhua Xiao,Huimin Yan,Lijian Hui,Ke Lan,Sidong Xiong,Xiaoxia Li,Zhong Huang,Hui Xiao
DOI: https://doi.org/10.1007/s12250-015-3606-3
2015-01-01
Abstract:Although IL-12 plays a critical role in priming Th1 and cytotoxic T lymphocyte(CTL) responses, Toll-like receptor(TLR) signaling only induces low amounts of IL-12 in dendritic cells and macrophages, implying the existence of stringent regulatory mechanisms. In this study, we sought to uncover the mechanisms underlying TLR-induced IL-12 expression and the Th1 response. By systemic screening, we identified a number of protein kinases involved in the regulation of TLRinduced IL-12 expression. In particular, PI3 K, ERK, and m TOR play critical roles in the TLR-induced Th1 response by regulating IL-12 and IL-10 production in innate immune cells. Moreover, we identified c-fos as a key molecule that mediates m TOR-regulated IL-12 and IL-10 expression in TLR signaling. Mechanistically, m TOR plays a crucial role in c-fos expression, thereby modulating NFκB binding to promoters of IL-12 and IL-10. By controlling the expression of a special innate gene program, m TOR can specifically regulate the TLR-induced T cell response in vivo. Furthermore, blockade of m TOR by rapamycin efficiently boosted TLR-induced antigen-specific T and B cell responses to HBV and HCV vaccines. Taken together, these results reveal a novel mechanism through which m TOR regulates TLR-induced IL-12 and IL-10 production, contributing new insights for strategies to improve vaccine efficacy.
What problem does this paper attempt to address?